|
市場調査レポート
商品コード
1499437
フェムテック市場:オファリング別、用途別、最終用途別-2024~2030年の世界予測Femtech Market by Offering (Products, Services, Software), Application (Fitness & Nutrition, General Health, Gynecology & Sexual Health), End-Use - Global Forecast 2024-2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
フェムテック市場:オファリング別、用途別、最終用途別-2024~2030年の世界予測 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
|
フェムテック市場規模は2023年に359億1,000万米ドルと推定され、2024年には408億5,000万米ドルに達し、CAGR 14.47%で2030年には925億1,000万米ドルに達すると予測されます。
フェムテックは、女性の健康に焦点を当てた技術を使用するソフトウェア、診断、製品、サービスのカテゴリーです。これには、不妊治療ソリューション、生理記録アプリ、妊娠・看護ケア、生殖器系の健康、一般的な健康など、さまざまなアプリケーションが含まれます。フェムテックの目標は、技術を活用して女性特有の健康課題に取り組み、女性の健康とウェルビーイングのニーズに合わせた革新的なソリューションを提供することです。月経障害、不妊症、更年期障害など、女性の健康問題の高い普及率が、フェムテック市場が提供する革新的なソリューションへのニーズを後押ししています。しかし、サイバーセキュリティに対する懸念が、フェムテック市場の成長を大きく妨げています。データ漏洩や機密性の高い健康情報への不正アクセスを恐れる消費者や医療プロバイダーが、フェムテックソリューションの採用を控えているからです。フェムテック製品とサービスにおける継続的な技術革新は、カスタマイズ製品の利用可能性の増加と相まって、フェムテック市場拡大の機会を提供しています。
主要市場の統計 | |
---|---|
基準年[2023年] | 359億1,000万米ドル |
予測年[2024年] | 408億5,000万米ドル |
予測年[2030年] | 925億1,000万米ドル |
CAGR(%) | 14.47% |
地域別洞察
南北アメリカ、特に北米では、確立された医療インフラと高い消費者意識から市場は恩恵を受け、不妊治療追跡アプリ、ウェアラブル健康機器、遠隔医療サービスなどのイノベーションに対する旺盛な需要を牽引しています。この地域の企業は、充実した投資環境と活発なベンチャーキャピタルの存在を活用しています。アジア太平洋は、デジタル導入の増加、都市化、女性の健康問題に対する意識の高まりが市場成長の原動力となっています。中国の高度な技術インフラと人口の多さが、リプロダクティブ・ヘルス向けのモバイルヘルス・アプリやウェアラブルを促進しています。日本は高齢化が進み、高品質な健康製品への需要が不妊治療やウェルネス・トラッキングへの投資に拍車をかけています。一方、インド市場は、女性の健康のための手頃なモバイルアプリケーションと遠隔医療サービスで繁栄しています。欧州、中東、アフリカ地域では、先進的な医療政策と性別に特化した医療研究への注目の高まりに支えられ、欧州、中東、アフリカのフェムテック市場が拡大しています。特に欧州諸国では、規制や資金調達の機会が充実しているため、フェムテックの新興企業にとって有利な環境が整っています。中東の市場は徐々に拡大しており、不妊治療や妊産婦ケアへの関心が高まっています。アフリカのフェムテック市場は、医療アクセスの課題に対処するため、アクセスしやすいリプロダクティブ・ヘルス教育、月経衛生用品、モバイルヘルスサービスに焦点を当て、台頭しつつあります。
FPNVポジショニングマトリックス
FPNVポジショニングマトリックスは、フェムテック市場におけるベンダーの市場ポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、フェムテック市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と推奨
戦略分析は、世界市場で確固たる足場を築こうとする組織にとって不可欠です。企業は、フェムテック市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
[197 Pages Report] The Femtech Market size was estimated at USD 35.91 billion in 2023 and expected to reach USD 40.85 billion in 2024, at a CAGR 14.47% to reach USD 92.51 billion by 2030.
Femtech is a category of software, diagnostics, products, and services that use technology for focusing on women's health. This includes various applications such as fertility solutions, period-tracking apps, pregnancy and nursing care, reproductive system health, and general wellness. The goal of femtech is to leverage technology to address women's unique health challenges and provide innovative solutions tailored to women's health and wellbeing needs. The high prevalence of women's health issues, such as menstrual disorders, fertility issues, and menopause-related problems, is driving the need for innovative solutions provided by the femtech market. However, cybersecurity concerns significantly hinder the growth of the femtech market as the fear of data breaches and unauthorized access to sensitive health information deters consumers and healthcare providers from adopting femtech solutions. The ongoing innovations in femtech products and services, coupled with the increasing availability of customized products, offers an opportunity for the expansion of the femtech market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 35.91 billion |
Estimated Year [2024] | USD 40.85 billion |
Forecast Year [2030] | USD 92.51 billion |
CAGR (%) | 14.47% |
Regional Insights
In the Americas, particularly in North America, the market benefits from well-established healthcare infrastructure and higher consumer awareness, driving robust demand for innovations, such as fertility tracking apps, wearable health devices, and telehealth services. Companies in this region capitalize on the substantial investment climate and active venture capital presence. The Asia-Pacific region is showcasing market growth fueled by increasing digital adoption, urbanization, and rising awareness of women's health issues. China's advanced tech infrastructure and large population foster mobile health apps and wearables for reproductive health. Japan's aging population and demand for high-quality health products fuel fertility treatments and wellness tracking investments. Meanwhile, India's market thrives with affordable mobile applications and telehealth services for women's health. In the EMEA region, the femtech market is expanding, supported by progressive healthcare policies and a growing focus on gender-specific medical research. European countries, in particular, showcase a favorable environment for femtech startups due to supportive regulations and funding opportunities. The market in the Middle East is gradually growing, with rising interest in fertility treatments and maternal care as awareness grows. Africa's femtech market is emerging, focusing on accessible reproductive health education, menstrual hygiene products, and mobile health services to address healthcare access challenges.
Market Insights
The market dynamics represent an ever-changing landscape of the Femtech Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Femtech Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Femtech Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Strategic Merger Strengthens Keleya's Position in FemTech Market
In a strategic move to enhance support for pregnant women and new mothers, digital platforms keleya and Kinderheldin are merging to operate collectively under the keleya brand. This merger broadens keleya's service portfolio and also consolidates partnerships with 65 health insurance companies, covering about 65% of insured persons in Germany. This merger is poised to significantly impact the FemTech market by extending accessible, expert-led maternal care to a broader audience. [Published On: 2024-05-02]
Launch of Femtech Canada Marks a Milestone in Women's Health Innovation
Femtech Canada, a pioneering women's health network initiative by Innovation Factory, officially launched in Toronto, Ontario, devoted to women's health innovation, commercialization, and investment. The initiative aims to serve the health and wellness needs of women, girls, non-binary individuals, trans people, and those assigned female at birth, promoting a more inclusive healthcare environment. [Published On: 2024-02-01]
Strategic Merger to Propel Growth in Swedish Femtech Market
Peptonic, known for its medical treatments and lifestyle products, and Pharmiva, currently launching Vernivia for bacterial vaginosis treatment, have announced plans to merge to enhance both companies' market positioning and product offerings. The merger, expected to foster growth and expansion into new markets, must be approved by both companies' boards and an extraordinary general meeting in Pharmiva. [Published On: 2023-06-19]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Femtech Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Femtech Market, highlighting leading vendors and their innovative profiles. These include Allara Health, Apple Inc., Athena Feminine Technologies, Athena Feminine Technologies, Inc., AVA Sciences by FemTech Health, Bloomlife, Canopie Inc., Carrot Fertility, Inc., Chiaro Technology Limited, Chorus Health Inc., Cleo Labs, Inc., Clue by Biowink GmbH, Elektra Health, Elvie, Everlywell, Inc., Fitbit LLC by Google, Inc., Flo Health UK Limited, Flo Health, Inc., FOLX Health, Inc., Future Family, Inc., Garmin Ltd., Glow Inc., HeraMED, INTIMINA, iSono Health, Kindbody, Koninklijke Philips N.V., Maven Clinic Co., Natural Cycles USA Corp, NextGen Jane, NUROKOR Ltd., Nuvo Cares, Nuvo Group Ltd., Organon & Co., Renovia Inc., Rosy Wellness, Inc., Rume Medical Group, Inc., Samsung Electronics Co., Ltd., Sera Prognostics, Thirty Madison company, Tia, Inc., Unified Women's Healthcare, Univfy Inc., Willow Innovations, Inc., and Wolomi.
Market Segmentation & Coverage